Skip to main content
SpringerLink
Log in
Book cover

Therapieresistente Depressionen pp 110–118Cite as

Selektive Serotonin-Wiederaufnahmehemmer (SSRI) bei therapieresistenten und schweren Depressionen

  • Conference paper

  • 76 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Altamura AC, Montgomery SA, Wernicke JF (1988) The evidence for 20 mg of fluoxetine as the optimal dose in the treatment of depression. Brit J Psychiatr 153 (suppl. 3): 109–112

    Google Scholar 

  • Amsterdam JD, Maislin G, Potter L (1994) Fluoxetine efficacy in treatment resistant depression. Prog Neuropsychopharmacol Biol Psychiat 18: 243–261

    Article  CAS  Google Scholar 

  • Anderson IM, Tomenson BM (1994) The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 8: 238–249

    Article  PubMed  CAS  Google Scholar 

  • Anderson IM, Tomenson BM (1995) Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. Brit Med J 310: 1433–1438

    Article  PubMed  CAS  Google Scholar 

  • Bauer M, Hellweg R, Baumgartner A (1996) Fluoxetine-induced akathisia does not reappear after switching to paroxetine. J Clin Psychiatry, im Druck

    Google Scholar 

  • Beasley CM, Sayler ME, Cunningham GE, Weiss AM, Masica DN (1990) Fluoxetine in tricyclic refractory major depressive disorder. J Affect Disorders 20: 193–200

    Article  PubMed  Google Scholar 

  • Beasley CM, Dornseif BE, Bosomworth JC, Saylor ME, Rampsey AH, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN (1991) Fluoxetine and suicide: A meta-analysis of controlled trials of treatment for depression. Br Med J 303: 685–691

    Google Scholar 

  • Boyer WF, Feighner JP (1991) The efficacy of selective serotonin re-uptake inhibitors in depression. In: Feighner JP, Boyer WF (eds) Selective serotonin re-uptake inhibitors. Wiley & Sons, Chichester, pp. 89–108

    Google Scholar 

  • Coulter DM, Pillans PI (1995) Fluoxetine and extrapyramidal side effects. Am J Psychiatry 152: 122–125

    PubMed  CAS  Google Scholar 

  • Delgado PL, Price LH, Charney DS, Heninger GR (1988) Efficacy of fluvoxamine in treatment-refractory depression. J Affect Disord 15: 55–60

    Article  PubMed  CAS  Google Scholar 

  • Dornseif BE, Dunlop SR, Potvin JH, Wernicke JF (1989) Effect of dose-escalation after low-dose fluoxetine therapy. Psychopharmacol Bull 25 (1): 71–79

    PubMed  CAS  Google Scholar 

  • Edwards J (1995) Suicide and antidepressants. Brit Med J 310: 205–206

    Article  PubMed  CAS  Google Scholar 

  • Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM (1994) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry 151: 1372–1374

    PubMed  CAS  Google Scholar 

  • Fuller RW, Wong DT (1987) Serotonin reuptake blockers in vitro and in vivo. J Clin Psychopharmacol 7: 14–20

    Article  Google Scholar 

  • Gatti F, Bellini L, Gasperini M, Perez J, Zanardi R, Smeraldi E (1996) Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry 153: 414–416

    PubMed  CAS  Google Scholar 

  • Henry JA, Alexander CA, Sener EK (1995) Relative mortality from overdose of antidepressants. Brit Med J 310: 221–224

    Article  PubMed  CAS  Google Scholar 

  • Jick SS, Den AD, Jick H (1995) Antidepressants and suicide. Brit Med J 310: 215–218

    Article  PubMed  CAS  Google Scholar 

  • Jönsson B, Bebbington PE (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatr 164: 665–673

    Article  Google Scholar 

  • Kasper S, Fuger J, Möller HJ (1992) Comparative efficacy of antidepressants. Drugs 43 (Suppl. 2): 11–23

    Article  PubMed  Google Scholar 

  • Kasper S, Möller HJ (1995) Antidepressive Psychopharmakotherapie. Dt Ärztebl 92: A428–434

    Google Scholar 

  • Lane R, Baldwin D, Preskorn S (1995) The SSRIs: advantages, disadvantages and differences. J Psychopharmacol 9 (Suppl.): 163–178

    PubMed  CAS  Google Scholar 

  • McCombs JS, Nichol MB, Stimmel GL, Sclar DA, Beasley CM, Gross LS (1990) The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in the Medicaid population. J Clin Psychiatr 51 (suppl. 6): 60–69

    Google Scholar 

  • Montgomery SA (1993) Suicide prevention and serotonergic drugs. Int Clin Psychopharmacol 8 (suppl.2): 83–85

    Article  PubMed  Google Scholar 

  • Montgomery SA, Henry JA, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D (1994) Selective serotonin reuptake inhibitors-meta-analysis of discontinuation rates. Int Clin Psychopharmacol 9: 47–53

    Article  PubMed  CAS  Google Scholar 

  • Nelson JC, Mazure CM, Bowers MB, Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48: 303–307

    Article  PubMed  CAS  Google Scholar 

  • Nolen WA, van de Pute JJ, Dijken WA, Kamp JS, Blansjaar BA, Kramer HJ, Haffmans J (1988) Treatment strategy in depression. Acta Psychiatr Scand 78: 668–675

    Article  PubMed  CAS  Google Scholar 

  • Rickets K, Schweizer E (1990) Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 51 ( Suppl. B): 9–12

    Google Scholar 

  • Roose SP (1994a) Selective serotonin reuptake inhibitors in refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. Wiley & Sons, Chichester, pp 37–46

    Google Scholar 

  • Roose SP, Glassmann AH, Attia E, Woodring S (1994b) Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151: 1735–1739

    PubMed  CAS  Google Scholar 

  • Seth R, Jennings AL, Bindman J, Phillips J, Bergmann K (1992) Combination treatment of noradrenalin and serotonin reuptake inhibitors in resistant depression. Brit J Psychiatr 161: 56z - 565

    Article  Google Scholar 

  • Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Brit Med J 306: 683–687

    Article  PubMed  CAS  Google Scholar 

  • Tyrer P, Marsden CA, Casey P, Seivewright N (1987) Clinical efficacy of paroxetine in resistant depression. J Psychopharmacol 1: 251–257

    Article  PubMed  CAS  Google Scholar 

  • Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K (1989) Ftuoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 50: 447–449

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. Baethge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik und Poliklinik, Freien Universität Berlin, Eschenallee 3, 14050, Berlin, Deutschland

    Michael Bauer  & Anne Berghöfer (Ärztin) &  (Ärztin)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Baethge, C., Bauer, M. (1997). Selektive Serotonin-Wiederaufnahmehemmer (SSRI) bei therapieresistenten und schweren Depressionen. In: Bauer, M., Berghöfer, A. (eds) Therapieresistente Depressionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10500-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10500-9_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61675-7

  • Online ISBN: 978-3-662-10500-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation